COVAL

Schwarz Pharma AG

Application Filed: 2003-03-31
Trademark Application Details
Trademark Logo COVAL

Mark For: COVAL™ trademark registration is intended to cover the categories of pharmaceutical products and substances, namely, analgesic/antirheumatic agents, antidimentia medications, nootropic medications, antiepileptic medications, dehabituating medications, hypnotic and sedative agents, neuropathological preparations and other neurotropic agents, antispasmotic medications, anti-parkinson agents and other agents effective against extrapyramidal disturbances, psychopharma-cological agents, antihypertonic medications, agents for arterio-sclerosis, beta-receptor blockers and calcium channel blockers, inhibitors of the renin-angiotensin system, diuretic agents, agents promoting circulation, lipid suppressors, gastrointestinal agents, medications for migraine, urologic medications. [all]

Status

2022-06-26 UTC
DEAD APPLICATION Refused Dismissed or Invalidated
This trademark application was refused, dismissed, or invalidated by the Office and this application is no longer active.


Research OneLook Acronym Finder
Serial Number76503449
Mark Literal ElementsCOVAL
Mark Drawing Type1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationTMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED 2007-10-11
Basis1(b) 44(e)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentYes
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeJACOBSON HOLMAN PLLC
Attorney NameJOHN CLARKE HOLMAN
Attorney Docket NumberT33973US0
Law Office AssignedM70
Employee NameAWRICH, ELLEN

Timeline

2002-04-24Trademark Registered
2003-03-31Application Filed
2007-09-13Abandon
2007-10-11Location: TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
2007-10-11Status: Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this fi
2007-10-11Status: Dead/Abandoned
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Schwarz Pharma AG
AddressAlfred-Nobel-StraBe 10 D-40789, Monheim GERMANY
Legal Entity TypeCorporation
Legal Entity StateGERMANY

Documents

Attorney of Record

JOHN CLARKE HOLMAN
JACOBSON HOLMAN PLLC
THE JENIFER BUILDING
400 SEVENTH STREET, N.W.
WASHINGTON, D.C. 20004-2201

Good, Services, and Codes

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: PHARMACEUTICAL PRODUCTS AND SUBSTANCES, NAMELY, ANALGESIC/ANTIRHEUMAT
IC AGENTS, ANTIDIMENTIA MEDICATIONS, NOOTROP
IC MEDICATIONS, ANTIEPILEPT
IC MEDICATIONS, DEHABITUATING MEDICATIONS, HYPNOT
IC AND SEDATIVE AGENTS, NEUROPATHOLOGICAL PREPARATIONS AND OTHER NEUROTROP
IC AGENTS, ANTISPASMOT
IC MEDICATIONS, ANTI-PARKINSON AGENTS AND OTHER AGENTS EFFECTIVE AGAINST EXTRAPYRAMIDAL DISTURBANCES, PSYCHOPHARMA-COLOGICAL AGENTS, ANTIHYPERTON
IC MEDICATIONS, AGENTS FOR ARTERIO-SCLEROSIS, BETA-RECEPTOR BLOCKERS AND CALCIUM CHANNEL BLOCKERS, INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM, DIURET
IC AGENTS, AGENTS PROMOTING CIRCULATION, LIPID SUPPRESSORS, GASTROINTESTINAL AGENTS, MEDICATIONS FOR MIGRAINE, UROLOG
IC MEDICATIONS

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051PHARMACEUTICAL PRODUCTS AND SUBSTANCES, NAMELY, ANALGESIC/ANTIRHEUMATIC AGENTS, ANTIDIMENTIA MEDICATIONS, NOOTROPIC MEDICATIONS, ANTIEPILEPTIC MEDICATIONS, DEHABITUATING MEDICATIONS, HYPNOTIC AND SEDATIVE AGENTS, NEUROPATHOLOGICAL PREPARATIONS AND OTHER NEUROTROPIC AGENTS, ANTISPASMOTIC MEDICATIONS, ANTI-PARKINSON AGENTS AND OTHER AGENTS EFFECTIVE AGAINST EXTRAPYRAMIDAL DISTURBANCES, PSYCHOPHARMA-COLOGICAL AGENTS, ANTIHYPERTONIC MEDICATIONS, AGENTS FOR ARTERIO-SCLEROSIS, BETA-RECEPTOR BLOCKERS AND CALCIUM CHANNEL BLOCKERS, INHIBITORS OF THE RENIN-ANGIOTENSIN SYSTEM, DIURETIC AGENTS, AGENTS PROMOTING CIRCULATION, LIPID SUPPRESSORS, GASTROINTESTINAL AGENTS, MEDICATIONS FOR MIGRAINE, UROLOGIC MEDICATIONS

Trademark Filing History

DescriptionDateProceeding Number
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND2007-10-11
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE2007-10-11
NON-FINAL ACTION MAILED2007-03-12
NON-FINAL ACTION WRITTEN2007-03-0970703
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2006-09-07
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2006-03-07
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2005-09-0768171
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2005-03-07
UNRESPONSIVE/DUPLICATE PAPER RECEIVED2005-02-1473793
PAPER RECEIVED2005-02-14
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED2004-11-29
UNRESPONSIVE/DUPLICATE PAPER RECEIVED2004-03-15
PAPER RECEIVED2004-03-15
LETTER OF SUSPENSION MAILED2003-09-17
ASSIGNED TO EXAMINER2003-09-1670703

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed